American Heart Journal
Volume 150, Issue 4 , Pages 674-680 , October 2005

Outcomes in patients admitted for chest pain with renal failure and troponin I elevations

Presented in part in Orlando, Fla, at the Sessions of the American Heart Association Scientific Meetings, November 2003.

  • Michael C. Kontos, MD

      Affiliations

    • Department of Internal Medicine, Cardiology Division, Virginia Commonwealth University, Richmond, Va
    • Department Emergency Medicine, Virginia Commonwealth University, Richmond, Va
    • Department Radiology, Virginia Commonwealth University, Richmond, Va
    • Corresponding Author InformationReprint requests: Michael C. Kontos, MD, Room 7-074, Heart Station, North Hospital, PO Box 980051, Medical College of Virginia, 12th and Marshall Sts, Richmond, VA 23298-0051.
    • ,
  • Rajat Garg, MD

      Affiliations

    • Department of Internal Medicine, Cardiology Division, Virginia Commonwealth University, Richmond, Va
    • ,
  • F. Philip Anderson, PhD

      Affiliations

    • Department Pathology, Clinical Chemistry Division, Virginia Commonwealth University, Richmond, Va
    • ,
  • James L. Tatum, MD

      Affiliations

    • Department Radiology, Virginia Commonwealth University, Richmond, Va
    • ,
  • Joseph P. Ornato, MD

      Affiliations

    • Department Emergency Medicine, Virginia Commonwealth University, Richmond, Va
    • ,
  • Robert L. Jesse, MD, PhD

      Affiliations

    • Department of Internal Medicine, Cardiology Division, Virginia Commonwealth University, Richmond, Va

Received 10 May 2004 ,Accepted 21 November 2004.

References 

  1. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996;93:1651–1657
  2. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non–ST elevation myocardial infarction. JAMA. 2001;286:2405–2412
  3. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406–1432
  4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970–1062
  5. Alpert JS, Thygesen K, Bassand JP, et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–969
  6. Apple FS, Sharkey SW, Hoeft P, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis. 1997;29:399–403
  7. Bhayana V, Gougoulias T, Cohoe S, et al. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem. 1995;41:312–317
  8. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679–684
  9. Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89:1003–1008
  10. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974–980
  11. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 ab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) study investigators. N Engl J Med. 1999;340:1623–1629
  12. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  13. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601
  14. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes The PURSUIT trial investigators. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med. 1998;339:436–443
  15. Low–molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet. 1996;347:561–568
  16. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13:1709–1712
  17. McLaurin MD, Apple FS, Falahati A, et al. Cardiac troponin I and creatine kinase–MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency. Am J Cardiol. 1998;82:973–975
  18. McCullough PA, Nowak RM, Foreback C, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med. 2002;9:1389–1396
  19. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002;346:2047–2052
  20. Van Lente F, McErlean ES, DeLuca SA, et al. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol. 1999;33:471–478
  21. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116–123
  22. Kontos MC, Shah R, Fritz LM, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol. 2004;43:958–965
  23. Matetzky S, Friemark D, Feinberg MS, et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9. J Am Coll Cardiol. 1999;34:748–753
  24. McLaurin MD, Apple FS, Voss EM, et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 1997;43:976–982
  25. Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem. 1994;40:1790–1791
  26. Li D, Jialal I, Keffer J. Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure. Clin Chem. 1996;42:114–115
  27. Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945
  28. Aronow WS, Ahn C, Mercando AD, et al. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000;86:1142-43, A9.
  29. Fernandez JS, Sadaniantz A. Medical and revascularization management in acute coronary syndrome in renal patients. Semin Nephrol. 2001;21:25–35
  30. Jaffe AS, Ritter C, Meltzer V, et al. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. J Lab Clin Med. 1984;104:193–202
  31. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799–805
  32. Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med. 2003;138:917–924
  33. Spinler SA, Inverso SM, Cohen M, et al. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003;146:33–41
  34. Freeman RV, Mehta RH, Al Badr W, et al. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol. 2003;41:718–724
  35. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–375
  36. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–1548
  37. Rubenstein MH, Harrell LC, Sheynberg BV, et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation. 2000;102:2966–2972
  38. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203
  39. Anderson RJ, O'brien M, MaWhinney S, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int. 1999;55:1057–1062
  40. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clin Chem. 2001;47:587–588

PII: S0002-8703(04)00828-2

doi: 10.1016/j.ahj.2004.11.008

American Heart Journal
Volume 150, Issue 4 , Pages 674-680 , October 2005

Article Tools

* Image Usage & Resolution